French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy.

Details

Serval ID
serval:BIB_AA7C8F9CEC50
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Title
French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy.
Journal
Journal of Gene Medicine
Working group(s)
European Society of Gene Therapy
ISSN
1099-498X (Print)
ISSN-L
1099-498X
Publication state
Published
Issued date
2003
Volume
5
Number
1
Pages
82-84
Language
english
Notes
Publication types: Journal ArticlePublication Status: ppublish. Nicole Deglon fait partie de European Society of Gene Therapy. pdf type: SOCIETY COMMUNICATION
Keywords
Clinical Trials Data Monitoring Committees, Clinical Trials as Topic, Europe, Genetic Diseases, X-Linked/genetics, Genetic Diseases, X-Linked/therapy, Genetic Therapy/adverse effects, Genetic Therapy/legislation & jurisprudence, Humans, Severe Combined Immunodeficiency/genetics, Severe Combined Immunodeficiency/therapy
Pubmed
Web of science
Create date
13/12/2011 17:04
Last modification date
20/08/2019 15:14
Usage data